Accelrys Reports 5 Percent Q3 Revenue Uptick | GenomeWeb

NEW YORK (GenomeWeb News) – Accelrys today reported a 5 percent increase in revenues for its fiscal third quarter as a loss in the prior-year quarter swung to a profit.

For the three months ended Dec. 31, 2008, revenues increased to $20.6 million from $19.6 million for the prior-year period, Accelrys said.

The company posted net income of $1 million, or $.04 per share, compared to a net loss of $1.2 million, or $.05 per share, for the same quarter of the previous year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.